At last, the double-blind phase of the drug trial is complete, and I have moved on to the open label phase of the Pagoclone stuttering study. That means I'm definitely getting the real thing - not placebo - and I can finally get a clearer picture of what this drug can (and can't) do to help me control my speech.
Just a few days into it, but I'll be reporting back here soon.
